President-elect Donald Trump's pick of Robert F. Kennedy Jr. for secretary of health and human services has drawn the ire of ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback